Related references
Note: Only part of the references are listed.Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer's disease
Chong Zeng et al.
BEHAVIOURAL BRAIN RESEARCH (2022)
Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: a Systematic Review and Meta-Analysis
Samar A. Zailaie et al.
IMMUNOLOGICAL INVESTIGATIONS (2022)
Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease
Xin Gong et al.
ENEURO (2022)
Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics
Bidisha Roy et al.
GENES (2022)
Diagnostic and therapeutic potential of exosomes in Alzheimer's disease
Tania Soares Martins et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Therapeutic advances of miRNAs: A preclinical and clinical update
Chiranjib Chakraborty et al.
JOURNAL OF ADVANCED RESEARCH (2021)
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
Alberto Serrano-Pozo et al.
LANCET NEUROLOGY (2021)
Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS
Alexandre Brodovitch et al.
SCIENTIFIC REPORTS (2021)
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
Hannah Walgrave et al.
MOLECULAR NEURODEGENERATION (2021)
Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression
Siranjeevi Nagaraj et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
Alessandro Maglione et al.
GENES (2021)
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer's Disease
Ming Zhang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches (vol 20, pg 68, 2021)
Alberto Serrano-Pozo et al.
LANCET NEUROLOGY (2021)
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study
C. E. Leurs et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein
Wileidy Gomez et al.
AGING-US (2020)
LRRK2 in Parkinson disease: challenges of clinical trials
Eduardo Tolosa et al.
NATURE REVIEWS NEUROLOGY (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders
Oceane Perdaens et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Potential Roles of Exosomes in Parkinson's Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis
Haiyang Yu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Inflammation-related plasma and CSF biomarkers for sclerosis
Jesse Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4
Michael E. Belloy et al.
JAMA NEUROLOGY (2020)
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson's Disease
Simoneide S. Titze-de-Almeida et al.
CELLS (2020)
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Michael Benatar et al.
NEUROLOGY (2020)
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications
Marta Pajares et al.
CELLS (2020)
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Garam Kim et al.
NEURON (2020)
miR-132 improves the cognitive function of rats with Alzheimer's disease by inhibiting the MAPK1 signal pathway
Yiming Deng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease
Ida Manna et al.
PHARMACEUTICALS (2020)
Development of miRNA-based therapeutic approaches for cancer patients
Ryou-u Takahashi et al.
CANCER SCIENCE (2019)
The Alzheimer's Disease Clinical Spectrum Diagnosis and Management
Alireza Atri
MEDICAL CLINICS OF NORTH AMERICA (2019)
Systematic Review of miRNA as Biomarkers in Alzheimer's Disease
S. Swarbrick et al.
MOLECULAR NEUROBIOLOGY (2019)
Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein
Dilshan S. Harischandra et al.
SCIENCE SIGNALING (2019)
Meta-analyses identify differentially expressed micrornas in Parkinson's disease
Jessica Schulz et al.
ANNALS OF NEUROLOGY (2019)
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
Anju Singh et al.
MOLECULES (2019)
The Potential for microRNA Therapeutics and Clinical Research
Johora Hanna et al.
FRONTIERS IN GENETICS (2019)
CSF and blood biomarkers for Parkinson's disease
Lucilla Parnetti et al.
LANCET NEUROLOGY (2019)
microRNA dysregulation in neurodegenerative diseases: A systematic review
Camille A. Juzwik et al.
PROGRESS IN NEUROBIOLOGY (2019)
Disease Detection with Molecular Biomarkers: From Chemistry of Body Fluids to Nature-Inspired Chemical Sensors
Yoav Y. Broza et al.
CHEMICAL REVIEWS (2019)
State of the science on mild cognitive impairment (MCI)
Nicole D. Anderson
CNS SPECTRUMS (2019)
Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease
Qi Qian et al.
FASEB JOURNAL (2019)
Role of Post-Transcriptional Control of Calpain by miR-124-3p in the Development of Alzheimer's Disease
Yajun Zhou et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Kioomars Saliminejad et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Molecular biomarkers in multiple sclerosis
Tjalf Ziemssen et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Intranasal Administration of miR-146a Agomir Rescued the Pathological Process and Cognitive Impairment in an AD Mouse Model
Hui Mai et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Genetics of Parkinson's disease and related disorders
Pei-Lan Zhang et al.
JOURNAL OF MEDICAL GENETICS (2018)
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity?
Suzanne Chartier et al.
CELL AND TISSUE RESEARCH (2018)
Nimodipine attenuates tau phosphorylation at Ser396 via miR-132/GSK-3β pathway in chronic cerebral hypoperfusion rats
Zihu Tan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Inflammation in CNS neurodegenerative diseases
Jodie Stephenson et al.
IMMUNOLOGY (2018)
MicroRNA-125b regulates Alzheimer's disease through SphK1 regulation
Yan Jin et al.
MOLECULAR MEDICINE REPORTS (2018)
MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease
Paul M. McKeever et al.
MOLECULAR NEUROBIOLOGY (2018)
Functional miRNAs in breast cancer drug resistance
Weizi Hu et al.
ONCOTARGETS AND THERAPY (2018)
Current Strategies for Brain Drug Delivery
Xiaowei Dong
THERANOSTICS (2018)
Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter?
Gareth Pryce et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Oxidative stress and the amyloid beta peptide in Alzheimer's disease
C. Cheignon et al.
REDOX BIOLOGY (2018)
Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease
Mengke Qu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future
K. Blennow et al.
JOURNAL OF INTERNAL MEDICINE (2018)
C9orf72-mediated ALS and FTD: multiple pathways to disease
Rubika Balendra et al.
NATURE REVIEWS NEUROLOGY (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques
Florie Borel et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Importance of Functional Loss of FUS in FTLD/ALS
Shinsuke Ishigaki et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis
Lucas T. Vu et al.
NEUROTHERAPEUTICS (2017)
Genetics of Alzheimer's disease: From pathogenesis to clinical usage
Wen Shao et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Why do so many clinical trials of therapies for Alzheimer's disease fail?
Roy M. Anderson et al.
LANCET (2017)
Amyotrophic lateral sclerosis
Michael A. van Es et al.
LANCET (2017)
Diagnostic Utility of Cerebrospinal Fluid α-Synuclein in Parkinson's Disease: A Systematic Review and Meta-Analysis
Paolo Eusebi et al.
MOVEMENT DISORDERS (2017)
Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)
Rachel Waller et al.
NEUROBIOLOGY OF AGING (2017)
MicroRNAs underlying memory deficits in neurodegenerative disorders
Julia Hernandez-Rapp et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Biomarkers for Parkinson's Disease: Recent Advancement
Sharvari Lotankar et al.
NEUROSCIENCE BULLETIN (2017)
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects
Siranjeevi Nagaraj et al.
ONCOTARGET (2017)
MiR-124-3p attenuates hyperphosphorylation of tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells
Qingmei Kang et al.
ONCOTARGET (2017)
Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls
Hong Liu et al.
SCIENTIFIC REPORTS (2017)
Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
Jennifer Ngolab et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study
Yang Hu et al.
SCIENTIFIC REPORTS (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study
Stefan Presslauer et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study
Stefan Presslauer et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro et al.
ALZHEIMERS & DEMENTIA (2016)
Diagnosis of Neurodegenerative Diseases: The Clinical Approach
Manuel Gomez-Rio et al.
CURRENT ALZHEIMER RESEARCH (2016)
Multiple sclerosis: genetics, biomarkers, treatments
Pierre-Paul Axisa et al.
CURRENT OPINION IN NEUROLOGY (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Molecular modeling approach to explore the role of cathepsin B from Hordeum vulgare in the degradation of Aβ peptides
Maruti J. Dhanavade et al.
MOLECULAR BIOSYSTEMS (2016)
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
Nour K. Majbour et al.
MOLECULAR NEURODEGENERATION (2016)
Epidemiology of Parkinson's disease
A. Elbaz et al.
REVUE NEUROLOGIQUE (2016)
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network
Christine E. Briggs et al.
BRAIN RESEARCH (2015)
Amyloid- as a biomarker for Alzheimer's disease: quantification methods in body fluids
Sara Galozzi et al.
EXPERT REVIEW OF PROTEOMICS (2015)
Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor
Tarun Garg et al.
JOURNAL OF DRUG TARGETING (2015)
Serum microRNAs in sporadic amyotrophic lateral sclerosis
Axel Freischmidt et al.
NEUROBIOLOGY OF AGING (2015)
Adeno-Associated Virus-Mediated MicroRNA Delivery and Therapeutics
Jun Xie et al.
SEMINARS IN LIVER DISEASE (2015)
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
YaXing Gui et al.
ONCOTARGET (2015)
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
Neeta Garg et al.
BRAIN AND BEHAVIOR (2015)
Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers
Giovanni Lugli et al.
PLOS ONE (2015)
Molecular diagnostics of neurodegenerative disorders
Megha Agrawal et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden
Helga Westerlind et al.
BRAIN (2014)
Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers
Axel Freischmidt et al.
BRAIN (2014)
Glial cells in amyotrophic lateral sclerosis
T. Philips et al.
EXPERIMENTAL NEUROLOGY (2014)
MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
Takehiro Kiko et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Oxidized DJ-1 as a possible biomarker of Parkinson's disease
Yoshiro Saito
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2014)
MicroRNA Expression Aberration in Chinese Patients with Relapsing Remitting Multiple Sclerosis
Dan Yang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128
Yogita K. Adlakha et al.
MOLECULAR CANCER (2014)
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
Margherita Grasso et al.
MOLECULES (2014)
Reduced Alpha-Synuclein in Cerebrospinal Fluid in Synucleinopathies: Evidence From a Meta-analysis
Wataru Sako et al.
MOVEMENT DISORDERS (2014)
miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease
Roberto Tiribuzi et al.
NEUROBIOLOGY OF AGING (2014)
Soluble Beta-Amyloid Peptides, but Not Insoluble Fibrils, Have Specific Effect on Neuronal MicroRNA Expression
Jing Jing Li et al.
PLOS ONE (2014)
Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
Kasandra Burgos et al.
PLOS ONE (2014)
Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis
Chunxing Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
Lucilla Parnetti et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study
Kira S. Sheinerman et al.
AGING-US (2013)
Alteration of the microRNA network during the progression of Alzheimer's disease
Pierre Lau et al.
EMBO MOLECULAR MEDICINE (2013)
Environmental factors in multiple sclerosis
Alberto Ascherio
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis
J. Jaeger et al.
GENES AND IMMUNITY (2013)
Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis
Batia Kaplan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls
Lucia F. Cardo et al.
JOURNAL OF NEUROLOGY (2013)
Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis
Kevin B. Boylan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
The Genetics of Parkinson's Disease: Progress and Therapeutic Implications
Andrew B. Singleton et al.
MOVEMENT DISORDERS (2013)
pNfH is a promising biomarker for ALS
Jeban Ganesalingam et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Sex and gender issues in multiple sclerosis
Hanne F. Harbo et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease
Helen Ling et al.
BRAIN (2012)
Interleukin-1A-889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies
Xue Qin et al.
JOURNAL OF NEUROLOGY (2012)
Neuropathology of Sporadic Parkinson's Disease: Evaluation and Changes of Concepts
Kurt A. Jellinger
MOVEMENT DISORDERS (2012)
The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE
Rita J. Guerreiro et al.
NEUROBIOLOGY OF AGING (2012)
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Ke Zen et al.
MEDICINAL RESEARCH REVIEWS (2012)
Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's Disease
Sok Kean Khoo et al.
JOURNAL OF PARKINSONS DISEASE (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Identification of blood microRNAs associated to Parkinsonis disease
Regina Margis et al.
JOURNAL OF BIOTECHNOLOGY (2011)
Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways
Vivek Swarup et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis
Brian C. Kraemer et al.
ACTA NEUROPATHOLOGICA (2010)
Multiple sclerosis: Geoepidemiology, genetics and the environment
Ron Milo et al.
AUTOIMMUNITY REVIEWS (2010)
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Mei-Chen Liao et al.
BIOCHEMISTRY (2010)
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews et al.
HUMAN MOLECULAR GENETICS (2010)
What Are the Most Important Nonmotor Symptoms in Patients with Parkinson's Disease and Are We Missing Them?
David A. Gallagher et al.
MOVEMENT DISORDERS (2010)
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
Daryl A. Bosco et al.
NATURE NEUROSCIENCE (2010)
MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders
Olivier C. Maes et al.
CURRENT GENOMICS (2009)
Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis
Stacy J. Caillier et al.
JOURNAL OF IMMUNOLOGY (2008)
The impact of microRNAs on protein output
Daehyun Baek et al.
NATURE (2008)
Widespread changes in protein synthesis induced by microRNAs
Matthias Selbach et al.
NATURE (2008)
The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
Neri Mercatelli et al.
PLOS ONE (2008)
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression
Sebastien S. Hebert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Impact of recent genetic findings in Parkinson's disease
Christine Klein et al.
CURRENT OPINION IN NEUROLOGY (2007)
Molecular biomarkers
Omar F. Laterza et al.
DRUG INFORMATION JOURNAL (2007)
Prediction of Alzheimer's disease using the CSF A beta 42/A beta 40 ratio in patients with mild cognitive impairment
Oskar Hansson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Aluminum inhibits proteolytic degradation of amyloid β peptide by cathepsin D:: A potential link between aluminum accumulation and neuritic plaque deposition
Takashi Sakamoto et al.
FEBS LETTERS (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Axonal damage markers in cerebrospinal fluid are increased in ALS
J Brettschneider et al.
NEUROLOGY (2006)
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease
A Di Fonzo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis
MR Lincoln et al.
NATURE GENETICS (2005)
MicroRNAs regulate brain morphogenesis in zebrafish
AJ Giraldez et al.
SCIENCE (2005)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
LP Lim et al.
NATURE (2005)
The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE)
T Ziemssen et al.
AUTOIMMUNITY REVIEWS (2005)
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation
LF Sempere et al.
GENOME BIOLOGY (2004)
PEN-2 is an integral component of the γ-secretase complex required for coordinated expression of presenilin and nicastrin
H Steiner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
